Applied Molecular Transport Shares 2011-2026 | AMTI

Annual Shares Applied Molecular Transport

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
38.8 M	37.6 M	22.9 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
38.8 M	22.9 M	33.1 M

Quarterly Shares Applied Molecular Transport

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
39.8 M	39.3 M	39.2 M	39.2 M	38.9 M	38.7 M	38.6 M	38.6 M	38.4 M	38.1 M	35.2 M	35.1 M	34.8 M	13.9 M	7.42 M	7.36 M	7.36 M	7.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
39.8 M	7.36 M	29.9 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Grifols, S.A. GRFS	682 M	$ 7.68	-	$ 6.83 B	Spain
Altimmune ALT	88.1 M	$ 3.47	3.74 %	$ 306 M	USA
Amgen AMGN	538 M	-	-	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	46.7 M	-	-	$ 915 M	USA
I-Mab IMAB	187 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Heron Therapeutics HRTX	167 M	-	-	$ 130 M	USA
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	54.8 M	$ 218.0	-1.75 %	$ 5 B	Danmark
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	16.8 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.08 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	19.2 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	17.9 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	12.1 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Incyte Corporation INCY	195 M	$ 90.75	-0.03 %	$ 17.7 B	USA
Inovio Pharmaceuticals INO	22.2 M	$ 1.57	-0.63 %	$ 34.8 M	USA
Avenue Therapeutics ATXI	1.3 M	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	15.8 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	60.2 M	$ 12.91	1.33 %	$ 778 M	USA
Atreca BCEL	38.6 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	99.3 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
Inventiva S.A. IVA	39.2 M	$ 6.11	5.71 %	$ 138 M	France
Calithera Biosciences CALA	73.9 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	54.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	69.9 K	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	9.55 M	-	-74.18 %	$ 955 K	USA
Checkpoint Therapeutics CKPT	39.7 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	116 M	-	-7.23 %	$ 13 M	USA
KalVista Pharmaceuticals KALV	49.7 M	$ 16.73	-1.59 %	$ 831 M	Britain
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	164 M	$ 21.04	4.31 %	$ 3.46 B	USA
Kamada Ltd. KMDA	44.8 M	$ 8.27	0.24 %	$ 260 M	Israel
Karyopharm Therapeutics KPTI	122 K	$ 6.93	-9.17 %	$ 845 K	USA
Keros Therapeutics KROS	37.2 M	$ 11.17	1.92 %	$ 416 M	USA
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	166 M	$ 4.3	1.37 %	$ 714 M	Canada
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA